CD40LG and B-cell chronic lymphocytic leukemia: Having demonstrated that B-CLL cells activated by CD154+/gp350+ exosomes achieve an activated phenotype, we next wanted to assess whether these B-CLL cells became immunogenic to autologous EBV- and CLL-specific T cells.